StockNews.com Begins Coverage on Mannatech (NASDAQ:MTEX)

Stock analysts at StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX) in a report issued on Sunday. The brokerage set a “buy” rating on the stock.

Mannatech Stock Performance

NASDAQ MTEX opened at $8.01 on Friday. The company has a quick ratio of 0.62, a current ratio of 1.17 and a debt-to-equity ratio of 0.54. The stock has a market cap of $15.10 million, a price-to-earnings ratio of -12.71 and a beta of 1.17. Mannatech has a fifty-two week low of $6.75 and a fifty-two week high of $10.51. The business has a fifty day moving average of $7.74 and a 200-day moving average of $7.55.

Mannatech (NASDAQ:MTEX) last released its earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%. The firm had revenue of $27.74 million during the quarter.

Insiders Place Their Bets

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the stock in a transaction on Monday, September 9th. The stock was sold at an average price of $7.75, for a total transaction of $126,232.00. Following the transaction, the director now owns 54,721 shares of the company’s stock, valued at $424,087.75. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. 41.50% of the stock is owned by corporate insiders.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.